Ambulatory Surgery

Latest Issue of OR Manager
July 2024
Home Ambulatory Surgery

In-house 3D printing reduces hospital surgery times, costs

Editor's Note The medical 3D printing market is expected to double from $2 billion in 2022 to $4 billion by 2026, driven by customization, lower costs, and quick turnarounds, according to analysis from GlobalData. In a July 24 report on the analysis, Medical Device Network outlined this growth as well…

Read More

By: Matt Danford
July 26, 2024
Share

HCA reports strong Q2 performance, sees decline in labor costs

Editor's Note HCA Healthcare reported nearly $1.5 billion in net income for the second quarter (Q2), exceeding expectations, Modern Healthcare July 23 reports. The Nashville-based system attributed part of this success to a significant reduction in contract labor costs, which dropped by more than 25% compared to Q2 2023. This…

Read More

By: Tarsilla Moura
July 24, 2024
Share

One expert concerned over drug shortages record high

Editor's Note Erin Fox, senior pharmacy director at University of Utah Health who has been monitoring drug shortages for over 20 years, spoke to AP News in June of her concerns. Currently, the situation is worse than ever, with total active shortages hitting an all-time high of 323 (with 48…

Read More

By: Tarsilla Moura
July 24, 2024
Share

Trends in ASC industry as highlighted by one expert

Editor's Note As outpatient surgery continues to gain popularity and the need to cut costs persists, Becker’s ASC Review sat down with Jim Freund, managing partner for Physician Transaction Advisors, to discuss the below three key trends in the ambulatory surgery center (ASC) industry, per Becker’s July 18 article. Number…

Read More

By: Tarsilla Moura
July 24, 2024
Share

Sponsored Message

High-flow oxygen deemed safe for pediatric tubeless airway surgery

Editor's Note New findings show that compared to standard anesthetic methods, a new high-flow oxygen technique is just as safe as during tubeless upper airway surgery in children.  Published in The Lancet Respiratory Medicine, the University of Queensland research-- the High-Flow Oxygen for Children's Airway Surgery (HAMSTER) trial—was the focus of…

Read More

By: Matt Danford
July 22, 2024
Share

New report predicts surge in ASC volume over next decade

Editor's Note New findings from health consultant Sg2’s 2024 Impact of Change report projects a 21% increase in ambulatory surgery center (ASC) volume, to reach 44 million by 2034, ASC Focus July 8 reports. An aging population, better diagnostics, and epidemiological factors are driving this demand, Tori Richie, senior consulting…

Read More

By: Tarsilla Moura
July 17, 2024
Share

Sponsored Message

Hemodynamic stability, less intraop hypotension risk with remimazolam in outpatient IR procedures

Editor's Note New research indicates the anesthetic combination of remimazolam and fentanyl provides optimal hemodynamic stability for patients undergoing short outpatient interventional radiology (IR) procedures, Anesthesiology News July 16 reports. This study, presented at the 2024 annual meeting of the Society for Ambulatory Anesthesia, compared common anesthetic combinations at a…

Read More

By: Tarsilla Moura
July 17, 2024
Share

Deadline approaches for OR Manager Award nominations

Editor's Note What better way to advocate for perioperative nursing than spotlighting and celebrating exceptional leadership at a gathering of the entire industry? Our annual OR Manager Awards—OR Manager of the Year, PACU Leader of the Year, and Ambulatory Nurse Leader of the Year—aim to do just that, but time…

Read More

By: Matt Danford
July 16, 2024
Share

Study: Gastric bypass offers cardiovascular benefits regardless of weight loss

Editor's Note Roux-en-Y gastric bypass (RYGB) reduces cardiovascular risk factors independent of calorie restriction and weight loss, according to a recent study published in JAMA Surgery. News-Medical.Net reported on the study July 4. Bariatric surgery, particularly RYGB, is more effective than non-surgical treatments for significant weight reduction and lowering cardiovascular…

Read More

By: Matt Danford
July 15, 2024
Share

FDA announces Class 1 recalls for ventilator software, electrode pads

Editor's Note The US Food and Drug Administration (FDA) has classified recalls by Hamilton Medical and Megadyne as Class 1 events, the most severe category indicating risk of serious injury or death. According to the agency’s July 11 report, Hamilton Medical is correcting software for its HAMILTON-C6 Medical Ventilator to…

Read More

By: Matt Danford
July 12, 2024
Share
Live chat by BoldChat